Celgene Corporation Announces Unaudited Consolidated Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2017; Provides Earnings Guidance for the Full Year Ending December 31, 2018
For the full year, the company announced total revenue was $13,003 million compared to $11,229 million for the same period a year ago. Operating income was $4,707 million compared to $3,166 million for the same period a year ago. Income before income taxes was $4,314 million compared to $2,372 million for the same period a year ago. Net income was $2,940 million or $3.64 per diluted share compared to $1,999 million or $2.49 per diluted share for the same period a year ago. Net income adjusted was $6,016 million compared to $4,770 million for the same period a year ago. Diluted net income per common share adjusted was $7.44 compared to $5.94 for the same period a year ago.
The company provided earnings guidance for the full year ending December 31, 2018. For the year, the company expects to report: net income GAAP between $5,629 million and $5,934 million; net income adjusted between $6,743 million and $6,898 million; net income per diluted common share GAAP between $7.26 and $7.66; net income per diluted common share adjusted between $8.70 and $8.90; total revenue between $14.4 billion and $14.8 billion; GAAP operating margin of approximately 46.5%; adjusted operating margin of approximately 60.0%; and adjusted tax rate of approximately 18%.